Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by type
1.4.2. Market size breakdown, by treatment
1.4.3. Market size breakdown, by end user
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Type (2019–2030)
7.3. Market Revenue, by Treatment (2019–2030)
7.3.1. Medication market revenue, by type (2019–2030)
7.3.2. Surgery market revenue, by type (2019–2030)
7.3.2.1. Non-invasive market revenue, by type (2019–2030)
7.3.2.2. Minimally invasive market revenue, by type (2019–2030)
7.3.2.3. Traditional market revenue, by type (2019–2030)
7.4. Market Revenue, by End User (2019–2030)
7.5. Market Revenue, by Region (2019–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Type (2019–2030)
8.3. Market Revenue, by Treatment (2019–2030)
8.3.1. Medication market revenue, by type (2019–2030)
8.3.2. Surgery market revenue, by type (2019–2030)
8.3.2.1. Non-invasive market revenue, by type (2019–2030)
8.3.2.2. Minimally invasive market revenue, by type (2019–2030)
8.3.2.3. Traditional market revenue, by type (2019–2030)
8.4. Market Revenue, by End User (2019–2030)
8.5. Market Revenue, by Country (2019–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Type (2019–2030)
9.3. Market Revenue, by Treatment (2019–2030)
9.3.1. Medication market revenue, by type (2019–2030)
9.3.2. Surgery market revenue, by type (2019–2030)
9.3.2.1. Non-invasive market revenue, by type (2019–2030)
9.3.2.2. Minimally invasive market revenue, by type (2019–2030)
9.3.2.3. Traditional market revenue, by type (2019–2030)
9.4. Market Revenue, by End User (2019–2030)
9.5. Market Revenue, by Country (2019–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Type (2019–2030)
10.3. Market Revenue, by Treatment (2019–2030)
10.3.1. Medication market revenue, by type (2019–2030)
10.3.2. Surgery market revenue, by type (2019–2030)
10.3.2.1. Non-invasive market revenue, by type (2019–2030)
10.3.2.2. Minimally invasive market revenue, by type (2019–2030)
10.3.2.3. Traditional market revenue, by type (2019–2030)
10.4. Market Revenue, by End User (2019–2030)
10.5. Market Revenue, by Country (2019–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Type (2019–2030)
11.3. Market Revenue, by Treatment (2019–2030)
11.3.1. Medication market revenue, by type (2019–2030)
11.3.2. Surgery market revenue, by type (2019–2030)
11.3.2.1. Non-invasive market revenue, by type (2019–2030)
11.3.2.2. Minimally invasive market revenue, by type (2019–2030)
11.3.2.3. Traditional market revenue, by type (2019–2030)
11.4. Market Revenue, by End User (2019–2030)
11.5. Market Revenue, by Country (2019–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Type (2019–2030)
12.3. Market Revenue, by Treatment (2019–2030)
12.3.1. Medication market revenue, by type (2019–2030)
12.3.2. Surgery market revenue, by type (2019–2030)
12.3.2.1. Non-invasive market revenue, by type (2019–2030)
12.3.2.2. Minimally invasive market revenue, by type (2019–2030)
12.3.2.3. Traditional market revenue, by type (2019–2030)
12.4. Market Revenue, by End User (2019–2030)
12.5. Market Revenue, by Country (2019–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Type (2019–2030)
13.3. Market Revenue, by Treatment (2019–2030)
13.3.1. Medication market revenue, by type (2019–2030)
13.3.2. Surgery market revenue, by type (2019–2030)
13.3.2.1. Non-invasive market revenue, by type (2019–2030)
13.3.2.2. Minimally invasive market revenue, by type (2019–2030)
13.3.2.3. Traditional market revenue, by type (2019–2030)
13.4. Market Revenue, by End User (2019–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Type (2019–2030)
14.3. Market Revenue, by Treatment (2019–2030)
14.3.1. Medication market revenue, by type (2019–2030)
14.3.2. Surgery market revenue, by type (2019–2030)
14.3.2.1. Non-invasive market revenue, by type (2019–2030)
14.3.2.2. Minimally invasive market revenue, by type (2019–2030)
14.3.2.3. Traditional market revenue, by type (2019–2030)
14.4. Market Revenue, by End User (2019–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Type (2019–2030)
15.3. Market Revenue, by Treatment (2019–2030)
15.3.1. Medication market revenue, by type (2019–2030)
15.3.2. Surgery market revenue, by type (2019–2030)
15.3.2.1. Non-invasive market revenue, by type (2019–2030)
15.3.2.2. Minimally invasive market revenue, by type (2019–2030)
15.3.2.3. Traditional market revenue, by type (2019–2030)
15.4. Market Revenue, by End User (2019–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Type (2019–2030)
16.3. Market Revenue, by Treatment (2019–2030)
16.3.1. Medication market revenue, by type (2019–2030)
16.3.2. Surgery market revenue, by type (2019–2030)
16.3.2.1. Non-invasive market revenue, by type (2019–2030)
16.3.2.2. Minimally invasive market revenue, by type (2019–2030)
16.3.2.3. Traditional market revenue, by type (2019–2030)
16.4. Market Revenue, by End User (2019–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Type (2019–2030)
17.3. Market Revenue, by Treatment (2019–2030)
17.3.1. Medication market revenue, by type (2019–2030)
17.3.2. Surgery market revenue, by type (2019–2030)
17.3.2.1. Non-invasive market revenue, by type (2019–2030)
17.3.2.2. Minimally invasive market revenue, by type (2019–2030)
17.3.2.3. Traditional market revenue, by type (2019–2030)
17.4. Market Revenue, by End User (2019–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Type (2019–2030)
18.3. Market Revenue, by Treatment (2019–2030)
18.3.1. Medication market revenue, by type (2019–2030)
18.3.2. Surgery market revenue, by type (2019–2030)
18.3.2.1. Non-invasive market revenue, by type (2019–2030)
18.3.2.2. Minimally invasive market revenue, by type (2019–2030)
18.3.2.3. Traditional market revenue, by type (2019–2030)
18.4. Market Revenue, by End User (2019–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Type (2019–2030)
19.3. Market Revenue, by Treatment (2019–2030)
19.3.1. Medication market revenue, by type (2019–2030)
19.3.2. Surgery market revenue, by type (2019–2030)
19.3.2.1. Non-invasive market revenue, by type (2019–2030)
19.3.2.2. Minimally invasive market revenue, by type (2019–2030)
19.3.2.3. Traditional market revenue, by type (2019–2030)
19.4. Market Revenue, by End User (2019–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Type (2019–2030)
20.3. Market Revenue, by Treatment (2019–2030)
20.3.1. Medication market revenue, by type (2019–2030)
20.3.2. Surgery market revenue, by type (2019–2030)
20.3.2.1. Non-invasive market revenue, by type (2019–2030)
20.3.2.2. Minimally invasive market revenue, by type (2019–2030)
20.3.2.3. Traditional market revenue, by type (2019–2030)
20.4. Market Revenue, by End User (2019–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Type (2019–2030)
21.3. Market Revenue, by Treatment (2019–2030)
21.3.1. Medication market revenue, by type (2019–2030)
21.3.2. Surgery market revenue, by type (2019–2030)
21.3.2.1. Non-invasive market revenue, by type (2019–2030)
21.3.2.2. Minimally invasive market revenue, by type (2019–2030)
21.3.2.3. Traditional market revenue, by type (2019–2030)
21.4. Market Revenue, by End User (2019–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Type (2019–2030)
22.3. Market Revenue, by Treatment (2019–2030)
22.3.1. Medication market revenue, by type (2019–2030)
22.3.2. Surgery market revenue, by type (2019–2030)
22.3.2.1. Non-invasive market revenue, by type (2019–2030)
22.3.2.2. Minimally invasive market revenue, by type (2019–2030)
22.3.2.3. Traditional market revenue, by type (2019–2030)
22.4. Market Revenue, by End User (2019–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Type (2019–2030)
23.3. Market Revenue, by Treatment (2019–2030)
23.3.1. Medication market revenue, by type (2019–2030)
23.3.2. Surgery market revenue, by type (2019–2030)
23.3.2.1. Non-invasive market revenue, by type (2019–2030)
23.3.2.2. Minimally invasive market revenue, by type (2019–2030)
23.3.2.3. Traditional market revenue, by type (2019–2030)
23.4. Market Revenue, by End User (2019–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Type (2019–2030)
24.3. Market Revenue, by Treatment (2019–2030)
24.3.1. Medication market revenue, by type (2019–2030)
24.3.2. Surgery market revenue, by type (2019–2030)
24.3.2.1. Non-invasive market revenue, by type (2019–2030)
24.3.2.2. Minimally invasive market revenue, by type (2019–2030)
24.3.2.3. Traditional market revenue, by type (2019–2030)
24.4. Market Revenue, by End User (2019–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Type (2019–2030)
25.3. Market Revenue, by Treatment (2019–2030)
25.3.1. Medication market revenue, by type (2019–2030)
25.3.2. Surgery market revenue, by type (2019–2030)
25.3.2.1. Non-invasive market revenue, by type (2019–2030)
25.3.2.2. Minimally invasive market revenue, by type (2019–2030)
25.3.2.3. Traditional market revenue, by type (2019–2030)
25.4. Market Revenue, by End User (2019–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Type (2019–2030)
26.3. Market Revenue, by Treatment (2019–2030)
26.3.1. Medication market revenue, by type (2019–2030)
26.3.2. Surgery market revenue, by type (2019–2030)
26.3.2.1. Non-invasive market revenue, by type (2019–2030)
26.3.2.2. Minimally invasive market revenue, by type (2019–2030)
26.3.2.3. Traditional market revenue, by type (2019–2030)
26.4. Market Revenue, by End User (2019–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Type (2019–2030)
27.3. Market Revenue, by Treatment (2019–2030)
27.3.1. Medication market revenue, by type (2019–2030)
27.3.2. Surgery market revenue, by type (2019–2030)
27.3.2.1. Non-invasive market revenue, by type (2019–2030)
27.3.2.2. Minimally invasive market revenue, by type (2019–2030)
27.3.2.3. Traditional market revenue, by type (2019–2030)
27.4. Market Revenue, by End User (2019–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Type (2019–2030)
28.3. Market Revenue, by Treatment (2019–2030)
28.3.1. Medication market revenue, by type (2019–2030)
28.3.2. Surgery market revenue, by type (2019–2030)
28.3.2.1. Non-invasive market revenue, by type (2019–2030)
28.3.2.2. Minimally invasive market revenue, by type (2019–2030)
28.3.2.3. Traditional market revenue, by type (2019–2030)
28.4. Market Revenue, by End User (2019–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Type (2019–2030)
29.3. Market Revenue, by Treatment (2019–2030)
29.3.1. Medication market revenue, by type (2019–2030)
29.3.2. Surgery market revenue, by type (2019–2030)
29.3.2.1. Non-invasive market revenue, by type (2019–2030)
29.3.2.2. Minimally invasive market revenue, by type (2019–2030)
29.3.2.3. Traditional market revenue, by type (2019–2030)
29.4. Market Revenue, by End User (2019–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. Medtronic plc
31.1.1. Business overview
31.1.2. Product and service offerings
31.1.3. Key financial summary
31.2. Gynesonics Inc.
31.2.1. Business overview
31.2.2. Product and service offerings
31.3. Minerva Surgical Inc.
31.3.1. Business overview
31.3.2. Product and service offerings
31.3.3. Key financial summary
31.4. Hologic Inc.
31.4.1. Business overview
31.4.2. Product and service offerings
31.4.3. Key financial summary
31.5. Boston Scientific Corporation
31.5.1. Business overview
31.5.2. Product and service offerings
31.5.3. Key financial summary
31.6. Abbvie Inc.
31.6.1. Business overview
31.6.2. Product and service offerings
31.6.3. Key financial summary
31.7. Pfizer Inc.
31.7.1. Business overview
31.7.2. Product and service offerings
31.7.3. Key financial summary
31.8. INSIGHTEC Ltd.
31.8.1. Business overview
31.8.2. Product and service offerings
31.9. Sumitomo Pharma Co. Ltd.
31.9.1. Business overview
31.9.2. Product and service offerings
31.10. ObsEva SA
31.10.1. Business overview
31.10.2. Product and service offerings
31.10.3. Key financial summary
31.11. KARL STORZ SE & Co. KG
31.11.1. Business overview
31.11.2. Product and service offerings
31.12. CooperSurgical Inc.
31.12.1. Business overview
31.12.2. Product and service offerings
31.13. Johnson & Johnson
31.13.1. Business overview
31.13.2. Product and service offerings
31.13.3. Key financial summary
31.14. Lumenis Be Ltd.
31.14.1. Business overview
31.14.2. Product and service offerings
31.15. Stryker Corporation
31.15.1. Business overview
31.15.2. Product and service offerings
31.15.3. Key financial summary
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
Want a report tailored exactly to your business need?
Request CustomizationEmpowering Leaders Across the Globe
Leading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages